Patents Assigned to Intellectual Property Strategy Network, Inc.
  • Nasal vaccine for
    Patent number: 9833407
    Abstract: The present invention provides a nasal vaccine for Streptococcus pneumoniae, and a production method therefor. This nasal vaccine formulation for primates includes a complex of PspA, i.e. the vaccine antigen, and a nanogel in which hydrophobic cholesterol is added, as side chains, to pullulan having amino groups. Furthermore, the present invention provides a production method for the nasal vaccine formulation for primates.
    Type: Grant
    Filed: February 16, 2015
    Date of Patent: December 5, 2017
    Assignee: Intellectual Property Strategy Network, Inc.
    Inventors: Yoshikazu Yuki, Hiroshi Kiyono, Kazunari Akiyoshi, Shinichi Sawada